Mastitis
Mastitis is an inflammatory condition of the breast that most commonly develops during lactation, although it can also present in non-lactating patients. The clinical course of the disease is highly variable, ranging from localized inflammatory changes to bacterial infection, phlegmon, and the development of a breast abscess. In modern clinical practice, lactational mastitis is viewed not merely as an isolated infectious process, but rather as a spectrum of interconnected inflammatory conditions.
1. Etiology and Pathogenesis
The development of lactational mastitis involves several interrelated mechanisms, including the inflammatory response of the breast tissue, hyperlactation (milk oversupply), altered milk outflow, and, in some cases, bacterial infection. According to the Academy of Breastfeeding Medicine (ABM) clinical protocols, the mastitis spectrum encompasses the following conditions:
Breast Engorgement and Ductal Narrowing (Plugged Ducts): Against the backdrop of tissue edema and inflammatory changes, the outflow of milk may become compromised.
Inflammatory Mastitis: Localized inflammation that may present with pain, erythema, swelling, and occasionally systemic symptoms, without the obligate presence of a bacterial infection.
Bacterial Mastitis: A condition in which the clinical picture indicates a bacterial infection, potentially requiring targeted antibiotic therapy.
Phlegmon: A heterogeneous tissue mass lacking clearly defined borders, resulting from the ongoing inflammatory process.
Breast Abscess: A localized collection of purulent fluid (pus) that typically requires procedural drainage.
Predisposing factors for lactational mastitis include milk oversupply, abrupt changes in breastfeeding routines, infant latching difficulties, nipple trauma, and mechanical pressure on the breast tissue.
In cases of non-lactational mastitis, it is critical to evaluate other potential etiologies, including periductal inflammation, spontaneous bacterial infection, and other underlying breast pathologies.
2. Clinical Manifestations
The clinical presentation of mastitis depends on the intensity of the inflammatory process and the stage of the disease. The most commonly reported symptoms include:
Breast pain and increased tenderness (mastalgia);
Localized edema (swelling) and skin erythema;
Increased focal temperature (warmth over the affected area);
Tissue induration or a palpable breast mass;
Fever, chills, myalgia, and generalized malaise.
3. Diagnosis
The diagnosis of mastitis is primarily clinical, relying on a thorough history and physical examination. During the assessment, it is essential to consider the patient's lactation status, symptom duration, prior similar episodes, comorbidities, and any previously attempted treatments.
A breast ultrasound is indicated when there is clinical suspicion of an abscess or phlegmon, a persistent palpable mass, an inadequate response to conservative treatment, or overall diagnostic uncertainty.
Bacteriological culture of breast milk is particularly warranted in the following scenarios:
Lack of clinical improvement approximately 48 hours after initiating antibiotic therapy;
Recurrent mastitis episodes;
Unusual or severe clinical presentations;
Suspicion of a resistant pathogen, such as Methicillin-resistant Staphylococcus aureus (MRSA).
In cases of non-lactational or recurrent inflammation, as well as when a palpable nodule persists despite medical management, further diagnostic evaluation is mandatory to rule out other etiologies (e.g., inflammatory breast cancer).
4. Treatment: An Evidence-Based Approach
The management of mastitis must be carefully tailored to the clinical stage of the disease. It is crucial to recognize that not all cases of inflammatory mastitis require antibiotic therapy; conversely, symptomatic treatment alone is insufficient in the presence of an active bacterial infection or an abscess.
4.1. Conservative Management of Inflammatory Mastitis
In the initial stages of the inflammatory process, first-line recommendations include:
Cold compresses: To effectively reduce tissue swelling and alleviate pain;
Rest and adequate hydration;
Analgesics and anti-inflammatory medications (e.g., NSAIDs): Administered while considering the patient's individual clinical profile, contraindications, and compatibility with lactation;
Minimizing mechanical pressure: Advising against tight clothing or restrictive bras, and avoiding other mechanical irritants.
Note: Deep or painful breast massage, aggressive milk expression, and repeated attempts to "completely empty" the breast are strictly contraindicated. These interventions often exacerbate tissue trauma, worsen edema, and prolong the inflammatory process.
4.2. Breastfeeding and Milk Outflow Management
In the vast majority of mastitis cases, breastfeeding can and should be continued. Feeding should be conducted on-demand, maintaining a physiological feeding schedule without unnecessary overstimulation.
If the infant is temporarily unable to feed from the affected breast, gentle pumping or hand expression may be necessary to maintain maternal comfort and ensure an adequate milk supply for the infant. However, additional pumping solely for the purpose of "completely emptying" the breast is not recommended, as excessive stimulation can sustain or worsen hyperlactation.
The decision to continue breastfeeding in specific, complex cases should be evaluated based on the maternal and infant clinical status, the characteristics of the infection, and any required medical procedures.
4.3. Antibiotic Therapy
Antibiotic therapy is indicated when the clinical picture strongly suggests bacterial mastitis or when the condition continues to progress despite optimal conservative management.
When selecting an empiric antibiotic, the provider must consider:
The most likely bacterial pathogen;
Local antimicrobial resistance patterns;
The patient's medication allergy history;
Prior antibiotic exposure and the specific risk for MRSA;
The patient's current lactation status and overall comorbidities.
The choice of medication must be judicious. Treatment efficacy must be evaluated dynamically. The specific antibiotic agent and the duration of the course are determined on an individualized basis; self-prescription or arbitrary alterations to the regimen by the patient are unacceptable.
4.4. Management of Abscesses and Phlegmons
The presence of a breast abscess necessitates the drainage of the purulent collection. Ultrasound-guided fine-needle aspiration (FNA) is generally preferred as the first-line intervention; depending on the specific clinical scenario, catheter drainage or alternative surgical approaches may be indicated.
Bacteriological culture of the aspirated purulent material is essential to identify the causative organism and allow for targeted de-escalation or adjustment of antibiotic therapy.
In cases of phlegmon, close clinical observation is required, often supplemented by serial ultrasound evaluations, as a drainable fluid collection may evolve over time.
Crucially, the presence of an abscess does not automatically dictate the complete cessation of breastfeeding. The feasibility of continued nursing depends on the anatomical location of the drain, the condition of the incision/wound, and individual clinical circumstances.
5. Complications and Indications for Urgent Assessment
Potential complications of mastitis include breast abscess, phlegmon, and, rarely, severe systemic infection, including sepsis.
Emergent medical evaluation is warranted if the patient presents with rapidly expanding erythema or edema, severe or escalating localized pain, or a high-grade fever accompanied by a significant deterioration in their overall clinical status.
If symptoms fail to improve within 12–24 hours despite appropriate home care, a formal medical assessment is recommended. Furthermore, a lack of clinical improvement within approximately 48 hours of targeted antibiotic therapy signals a strong need for additional diagnostic workup.
6. Prevention and Patient Education
The prevention of mastitis is rooted in supporting the physiological processes of lactation, evaluating and correcting breastfeeding techniques, and mitigating risk factors that predispose the patient to recurrent glandular inflammation.
Practical preventive recommendations include:
Evaluating and correcting the infant's latch, involving a lactation consultant if necessary;
Maintaining a physiological, on-demand breastfeeding routine;
Preventing milk oversupply by avoiding excessive pumping or forced expression;
Addressing any factors contributing to nipple trauma;
Avoiding mechanical trauma and restrictive pressure on the breast tissue;
Seeking timely medical evaluation in the event of recurrent or treatment-resistant symptoms.
During patient education, it is vital to emphasize that breast pain, localized redness, and fever do not universally equate to a bacterial infection. Consequently, the necessity for antibiotics is not determined solely by a checklist of these symptoms.
Conclusion Mastitis represents a complex spectrum of inflammatory breast conditions. Successful management demands an accurate interpretation of the clinical presentation, precise disease staging, and highly individualized, patient-centric treatment plans.
The modern clinical paradigm requires differentiating between sterile inflammatory and active bacterial processes, championing antimicrobial stewardship, actively avoiding interventions that induce tissue trauma, and ensuring the timely identification and drainage of abscesses. Special emphasis must be placed on thorough patient education and the active support of continued breastfeeding whenever it is safe to do so.
Ultimately, the foundation of effective mastitis management rests on evidence-based clinical decision-making, vigilant follow-up, and the proactive assessment of complication risks.
Would you like to consult with a qualified mammologist and undergo diagnostic screening according to modern standards?
